NCT06472102

Brief Summary

Cardioneuroablation (CNA) is a new method for the treatment of asystolic reflex syncope, however, optimal methods for identification of presumed sites of ganglionated plexi (GP), which are the target for CNA and are located in the epicardial fat, have not yet been established. This study will compare the accuracy of three methods used for identification of these areas: intracardiac recordings of fractionated atrial electrograms, intracardiac echocardiography and computed tomography. The study group will consist of 100 patients undergoing CNA in our institution. The procedure will be performed in a standard manner with the use of extracardiac vagal stimulation as the intraprocedural end-point. Correlation between the three methods used for localisation of optimal sites for CNA as well as their predictive value for achieving effective CNA will be computed.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2024

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

June 15, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 26, 2025

Status Verified

September 1, 2025

Enrollment Period

1.6 years

First QC Date

June 15, 2024

Last Update Submit

September 23, 2025

Conditions

Keywords

cardioneuroablationsyncope

Outcome Measures

Primary Outcomes (1)

  • Predictive value of fragmented atrial potentials

    Sensitivity, specificity, positive and negative predictive value of fragmented atrial potentials for the acute efficacy of cardioneuroablation

    During procedure (2 hours)

Secondary Outcomes (5)

  • Localization of presumed areas of ganglionated plexi

    During procedure (2 hours)

  • Accuracy of identification of sites where effective cardioneuroablation was performed

    During procedure (2 hours)

  • Number of deflections of fragmented atrial potentials at inferior and superior areas of ganglionated plexi

    During procedure (2 hours)

  • Duration of fragmented atrial potentials at inferior and superior areas of ganglionated plexi

    During procedure (2 hours)

  • Amplitude of fragmented atrial potentials at inferior and superior areas of ganglionated plexi

    During procedure (2 hours)

Interventions

Endocardial radio-frequency ablation of areas of ganglionated plexi in the left and the right atrium

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • severe, recurrent symptoms due to reflex syncope with ECG documented asystole \>3 seconds, especially if associated with injury, or recurrent presyncope with persistent reflex bradycardia
  • history of ineffective prior non-pharmacological treatment and positive baseline atropine test (sinus rate acceleration \> 30% and no AV block following 2 mg of intravenous atropine) -
  • informed written consent obtained

You may not qualify if:

  • contraindications to perform cardioneuroablation
  • contraindications to perform computed tomography with intravenous contrast injection
  • lack of informed written consent obtained

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cardiology, Postgraduate Medical School, Grochowski Hospital

Warsaw, Masovian Voivodeship, 04-073, Poland

RECRUITING

Related Publications (5)

  • Pachon JC, Pachon EI, Pachon JC, Lobo TJ, Pachon MZ, Vargas RN, Jatene AD. "Cardioneuroablation"--new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005 Jan;7(1):1-13. doi: 10.1016/j.eupc.2004.10.003.

    PMID: 15670960BACKGROUND
  • Lellouche N, Buch E, Celigoj A, Siegerman C, Cesario D, De Diego C, Mahajan A, Boyle NG, Wiener I, Garfinkel A, Shivkumar K. Functional characterization of atrial electrograms in sinus rhythm delineates sites of parasympathetic innervation in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 2007 Oct 2;50(14):1324-31. doi: 10.1016/j.jacc.2007.03.069. Epub 2007 Sep 17.

    PMID: 17903630BACKGROUND
  • Aksu T, De Potter T, John L, Osorio J, Singh D, Alyesh D, Baysal E, Kumar K, Mikaeili J, Dal Forno A, Yalin K, Akdemir B, Woods CE, Salcedo J, Eftekharzadeh M, Akgun T, Sundaram S, Aras D, Tzou WS, Gopinathannair R, Winterfield J, Gupta D, Davila A. Procedural and short-term results of electroanatomic-mapping-guided ganglionated plexus ablation by first-time operators: A multicenter study. J Cardiovasc Electrophysiol. 2022 Jan;33(1):117-122. doi: 10.1111/jce.15278. Epub 2021 Oct 25.

    PMID: 34674347BACKGROUND
  • Kulakowski P, Baran J, Sikorska A, Krynski T, Niedzwiedz M, Soszynska M, Piotrowski R. Cardioneuroablation for reflex asystolic syncope: Mid-term safety, efficacy, and patient's acceptance. Heart Rhythm. 2024 Mar;21(3):282-291. doi: 10.1016/j.hrthm.2023.11.022. Epub 2023 Nov 29.

    PMID: 38036236BACKGROUND
  • Francia P, Viveros D, Falasconi G, Soto-Iglesias D, Fernandez-Armenta J, Penela D, Berruezo A. Computed tomography-based identification of ganglionated plexi to guide cardioneuroablation for vasovagal syncope. Europace. 2023 Jun 2;25(6):euad170. doi: 10.1093/europace/euad170.

    PMID: 37343139BACKGROUND

MeSH Terms

Conditions

Syncope, VasovagalSyncope

Condition Hierarchy (Ancestors)

Orthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesNervous System DiseasesUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Roman Piotrowski, MD PhD

    Department of Cardiology, Grochowski Hospital, Medical Centre for Postgraduate Education

    STUDY DIRECTOR

Central Study Contacts

Piotr Kułakowski, MD PhD

CONTACT

Agnieszka Sikorska, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 15, 2024

First Posted

June 24, 2024

Study Start

May 20, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

September 26, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

To share with other investigators study details upon reasonable requests

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
From December 2025 to December 2027
Access Criteria
e-mail contacts

Locations